NCT06135233 (E-MIPS) is a clinical trial of No intervention in Pancreas Disease, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Who is sponsoring NCT06135233?

NCT06135233 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

What drugs are being tested in NCT06135233?

Interventions in NCT06135233: No intervention.

What condition does NCT06135233 study?

NCT06135233 studies Pancreas Disease.

Is NCT06135233 still recruiting?

NCT06135233 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06135233: E-MIPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:

Completed Last updated 18 November 2023

What this trial tests

trial testing No intervention in Pancreas Disease in 1,336 participants. Completed in 1 January 2022.

Timeline

1 January 2019

Primary endpoint
31 December 2021

1 January 2022

Quick facts

Lead sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,336
Start date	1 January 2019
Primary completion	31 December 2021
Estimated completion	1 January 2022
Sites	1 location across Netherlands

Drugs / interventions tested

No intervention

Conditions studied

Pancreas Disease — all drugs for Pancreas Disease →

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

18 and older, any sex, with Pancreas Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registry.
Emmen AMLH, de Graaf N, Khatkov IE, Busch OR, et al · · 2024 · cited 6× · PMID 38265434 · DOI 10.1097/js9.0000000000001121

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Pancreas Disease

Currently open trials in the same condition.

NCT07263061 — Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries · recruiting
NCT05714111 — Radiology Registry on Pancreatic Malignancies · recruiting
NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
NCT03260842 — Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer · recruiting

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

NCT07301021 — Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients · not yet recruiting
NCT07359482 — sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 · Phase 3 · not yet recruiting
NCT07457957 — Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents · NA · not yet recruiting
NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06135233 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06135233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing